Antioxidant defense, under clinical direction.
Compounded injectable glutathione for clinician-guided antioxidant defense beyond the supplement aisle.
About 10 minutes. No charge unless your clinician approves.
This is not a detox trend. It is normal cellular chemistry.
Glutathione is a three-amino-acid molecule made inside your own cells from glycine, cysteine, and glutamate. Its reputation as the body’s “master antioxidant” comes from how centrally it sits inside antioxidant defense and conjugation chemistry, not from a wellness nickname invented for a supplement label.
That distinction is the reason to care.
Glutathione participates in neutralizing reactive oxygen species and in pathways the liver uses to conjugate compounds for processing. It also interacts with the wider antioxidant system, including the chemistry that helps recycle vitamins C and E. Those are ordinary physiological jobs your cells already depend on every day.
The injectable prescription changes the delivery route, not the biology. Instead of asking an oral product to pass through digestion first, the compounded medication is administered by injection on a schedule your clinician determines. The goal is not to promise a cleanse, immunity “boost,” or instant energy. It is to use a familiar endogenous molecule in a deliberate medical plan when your provider decides that route is appropriate.
Glutathione gives your clinician a defined endogenous molecule to consider for antioxidant defense and recovery support, with its physiological roles kept specific and its fit evaluated inside your broader plan.
Read the evidence →For people who want antioxidant support grounded in biology.
The Mechanism-First Patient
You are interested in oxidative stress, but you want the conversation grounded in what glutathione actually does inside cells rather than a vague promise to “cleanse” the body.
The Liver-Support Reader
You have heard glutathione discussed around detoxification and want the medically accurate version: it participates in normal hepatic conjugation chemistry. That is a real mechanism and not evidence that an injection removes a specific toxin from you.
The High-Demand Routine
Training, work, stress, and age have you thinking more seriously about recovery and cellular resilience. You want a clinician to decide whether glutathione belongs in that larger plan rather than adding another supplement by instinct.
Compounded glutathione is not an FDA-approved drug product. A licensed provider determines candidacy from your full intake, and results vary. This is not a chelation therapy and is not a treatment for heavy-metal exposure.
This might not be the right fit if:
- You are pregnant or breastfeeding.
- You have an active cancer or are being treated for one. Let your provider weigh in before starting any injectable.
- You have significant kidney or liver disease. This deserves a provider’s review before an injectable plan.
- You take a medication or carry a condition that needs a closer look before adding an injectable compound.
Your intake screens for all contraindications. Every candidate is evaluated by a licensed clinician before any prescription is issued. No prescription is issued without clearance.
Glutathione, prescribed with care.
Compounded by a licensed 503A pharmacy. Prescribed by a licensed provider after clinical review.
- Endogenous glutathione used as a compounded prescription injection
- Supports normal antioxidant and conjugation chemistry at the mechanism level
- Administration schedule set by your clinician
- Prepared to your individual prescription by a licensed 503A pharmacy
- Response and overall fit reviewed through ongoing care
Prescription issued subject to provider judgment. Results vary. Not a guarantee of outcomes.
*Price reflects a 3 month commitment. Other billing options are shown at checkout.
More in Longevity.
Semaglutide + B12 Microdose
A lower-dose path with B12 built in.
A lower-dose compounded semaglutide and B12 prescription for clinician-guided metabolic care at a different starting scale. (Contains semaglutide and vitamin B12.)
Tirzepatide + B12 Microdose
Dual-pathway biology at a lower starting scale.
A lower-dose compounded tirzepatide and B12 prescription that keeps dual-receptor biology inside clinician-led care. (Contains tirzepatide and vitamin B12.)
Metformin ER
Diabetes made it famous. Longevity made it interesting again.
FDA-approved generic metformin ER with decades of metabolic use and a serious place in the longevity conversation.
What the research shows
Neither intranasal glutathione dose beat placebo in Parkinson disease.
The detail
In a double-blind, placebo-controlled Phase IIb trial, 45 people with Hoehn and Yahr Stage 1 to 3 Parkinson disease received intranasal reduced glutathione at 100 mg or 200 mg, or placebo, three times daily for three months; the high-dose group improved on the total Unified Parkinson Disease Rating Scale over baseline, but neither glutathione dose was superior to placebo.1
Intravenous glutathione was well tolerated but showed no difference on the rating scale.
The detail
In a randomized, double-blind, placebo-controlled pilot trial, 21 people with Parkinson disease received intravenous glutathione at 1,400 mg or placebo three times weekly for four weeks; glutathione was well tolerated with reported adverse events similar to placebo, and there were no significant differences in Unified Parkinson Disease Rating Scale scores.2
A single intranasal dose raised brain glutathione for at least an hour.
The detail
In 15 participants with mid-stage Parkinson disease, a single 200 mg intranasal dose of reduced glutathione raised brain glutathione measured by magnetic resonance spectroscopy above baseline, an increase that persisted for at least one hour.3
Pain-free walking rose from 143 to 196 meters within the treated group.
The detail
In a randomized, double-blind, placebo-controlled trial of 40 patients with Fontaine stage II peripheral arterial disease, five days of twice-daily intravenous glutathione increased pain-free walking distance within the treated group from 143 to 196 meters and improved macrocirculatory flow after treadmill testing, while the saline group showed similar results before and after the infusion period.4
The review found no evidence establishing intravenous glutathione for skin lightening.
The detail
In a dermatology review of glutathione as a skin-lightening agent, the authors identified three randomized controlled trials supporting topical and oral glutathione but no evidence establishing the efficacy of intravenous glutathione injections, and noted that adverse effects prompted the Food and Drug Administration of the Philippines to issue a public warning against its use for off-label skin lightening.5
What it does not show
No randomized trial has tested compounded injectable glutathione for antioxidant support or healthy aging.
The detail
No randomized controlled trial has evaluated compounded injectable glutathione for general antioxidant support, cellular resilience, or healthy aging, which is the context in which it is offered here. The randomized trials of injected glutathione were conducted in defined disease populations rather than in healthy adults.
The Parkinson trials used different routes, and neither separated glutathione from placebo.
The detail
The Parkinson disease trials used routes and schedules that are not what is offered here: intranasal dosing three times daily, and intravenous infusion of 1,400 mg three times weekly. Neither trial separated glutathione from placebo on its clinical rating scale.
The walking result was a within-group change in a different route and population.
The detail
The peripheral arterial disease result came from five days of twice-daily intravenous infusion in patients with claudication, and the walking-distance improvement was a within-group change. That is a different route, duration, population, and comparison from an ongoing maintenance injection.
Established biochemistry does not show that a compounded glutathione injection produces clinical benefit.
The detail
The role of glutathione in antioxidant defense and in hepatic conjugation is established biochemistry, and the intranasal study shows that an administered dose can reach tissue. Neither establishes that a compounded glutathione injection produces a measurable clinical benefit, and no trial supports its use for detoxification or heavy-metal removal.
- Mischley LK, et al. Phase IIb study of intranasal glutathione in Parkinson's disease. J Parkinsons Dis. 2017.
- Hauser RA, et al. Randomized, double-blind, pilot evaluation of intravenous glutathione… Mov Disord. 2009.
- Mischley LK, et al. Central nervous system uptake of intranasal glutathione in Parkinson's… NPJ Parkinsons Dis. 2016.
- Arosio E, et al. Effect of glutathione infusion on leg arterial circulation, cutaneous… Mayo Clin Proc. 2002.
- Sonthalia S, et al. Glutathione as a skin whitening agent: facts, myths, evidence and… Indian J Dermatol Venereol Leprol. 2016.
Serious risks
- Liver dysfunction
- Severe abdominal pain
- Thyroid and kidney dysfunction
- Serious skin eruptions including Stevens-Johnson syndrome
- Anaphylaxis
Commonly reported
- Local to start: soreness, redness or swelling where you inject
- Glutathione also carries a mild sulfur smell that some people notice at the time of administration
Most of the documented harm comes from intravenous glutathione used for skin lightening, where regulators and reviewers have recorded those outcomes; several of the worst were traced to counterfeit product and unsterile administration rather than to glutathione itself. Your provider reviews cancer history, kidney and liver function, medications, pregnancy status and any previous drug reaction before prescribing. Controlled safety data for compounded injectable glutathione is limited, which is the reason this sits with a clinician rather than in a shopping cart.
Asked and answered.
You are not charged, and you are not left guessing. Your clinician explains the reasoning and, where it helps, what a better path might look like. Reviews are typically completed in under 24 hours.
Injection changes the delivery route by bypassing gastrointestinal absorption. Whether that difference is clinically meaningful for you is part of the prescribing decision. The route alone does not establish an advantage.
Response varies. Your clinician evaluates it from your actual experience rather than a preset timeline.
Glutathione is administered by injection on the schedule your clinician prescribes. The medication is prepared by a licensed 503A pharmacy, and questions about administration, response, or tolerability belong with your care team rather than being left to self-directed experimentation.
Glutathione is a molecule your own cells make and use every day, and it has a long history in compounding practice. No compounded medication is FDA-approved, including this one. Compounded medicines are made to your individual prescription by a licensed pharmacy rather than manufactured and approved as a finished drug product. Your provider will discuss this as part of your evaluation.
Any time, before your renewal date. No phone calls required.